FDA Adverse Event Malfunction Summary report: N

BD LUER-LOK

MDR report key: 19899775 · Received August 2, 2024

Report

Report Number
1213809-2024-00517
Event Type
Malfunction
Date Received
August 2, 2024
Date of Event
July 11, 2024
Report Date
July 19, 2024
Manufacturer
BECTON DICKINSON MEDICAL SYSTEMS
Product Code
FMF
PMA / PMN Number
K110771
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: SINCE NO SAMPLES DISPLAYING THE CONDITION REPORTED ARE AVAILABLE FOR EXAMINATION, WE WERE UNABLE TO FULLY INVESTIGATE THIS INCIDENT. NO ROOT CAUSE CAN BE DETERMINED AS NO SAMPLES WERE RECEIVED. FURTHERMORE, A DEVICE HISTORY RECORD REVIEW SHOWED NO REJECTED INSPECTIONS OR QUALITY ISSUES DURING THE PRODUCTION OF THE PROVIDED LOT NUMBER THAT COULD HAVE CONTRIBUTED TO THE REPORTED DEFECT. EXAMINATION OF THE PRODUCT INVOLVED MAY PROVIDE CLARIFICATION AS TO THE CAUSE FOR THE REPORTED FAILURE. WE APPRECIATE YOU TAKING THE TIME TO BRING THIS OBSERVATION TO OUR ATTENTION. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. INFORMATION WILL BE CAPTURED ON TREND REPORTS AND MONITORED MONTHLY. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BD LUER-LOK BARREL CRACKED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER TRANSLATED FROM FRENCH TO ENGLISH: KESAVA RAJ M: 18-JUL-2024 FOLLOW-UP 1ST ATTEMPT COMMENTS (REC): " FIELD BELOW 1. PLEASE CONFIRM THE NUMBER OF PRODUCTS AFFECTED. ="FOR THE MOMENT, 1 SYRINGE." 2. HAS THERE BEEN ANY PATIENT IMPACT (SERIOUS INJURY, MEDICAL INTERVENTION, CHANGE OF TREATMENT REQUIRED)? ="TREATMENT HAD TO BE RE-PREPARED. NO CLINICAL IMPACT ON THE PATIENT." 3. HAS THERE BEEN ANY HEALTHCARE WORKER¿S EXPOSURE TO BLOOD OR BODILY FLUIDS? ="NO". 4. HAVE ANY OTHER ACTIONS BEEN TAKEN? ="NO". 5. WERE THERE ANY NEGATIVE CONSEQUENCES FOR THE OPERATOR DUE TO THE LEAK OR FOR PATIENTS DUE TO THE MISSED ADMINISTRATION? ="LOSS OF TIME FOR NURSING STAFF, PREPARATION STAFF. WAITING TIME FOR INPATIENTS IN HDJ (DAY HOSPITAL)." 6. COULD YOU PROVIDE A NAME OF CHEMOTHERAPY MEDICATION THAT HAS BEEN USED WITH THE PRODUCT? ="THE INN OF THE PRODUCT IS AZACITIDINE". AN INCIDENT THAT OCCURRED ON (B)(6) 2024, DURING THE USE OF THE PRODUCT: "3-PIECE LUER SYRINGE 3 ML " -REF: (B)(4). -LOT NUMBER: 0245450. -EXP: 31/08/2025. DURING THE ADMINISTRATION OF CHEMOTHERAPY, THE IDE (USER) NOTICED A LEAKAGE IN THE BARREL OF THE SYRINGE. THE SYRINGE WAS CRACKED. THE SYRINGE WAS DISCARDED AND IS THEREFORE NOT AVAILABLE FOR RETURN OR APPRAISAL. VISUALLY, AT THE TIME OF PREPARATION, THERE WERE NO VISIBLE CRACKS ON THE SYRINGE. THE SYRINGE CONTAINING AN ANTI-CANCER TREATMENT HAD TO BE REPROCESSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1037711 BD LUER-LOK PISTON SYRINGE FMF BECTON DICKINSON MEDICAL SYSTEMS 0245450

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown